Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study
Titel:
Randomized study of weekly irinotecan plus high-dose 5-fluorouracil (FUIRI) versus biweekly irinotecan plus 5-fluorouracil/leucovorin (FOLFIRI) as first-line chemotherapy for patients with metastatic colorectal cancer: a Spanish Cooperative Group for the Treatment of Digestive Tumors Study
Auteur:
Aranda, E. Valladares, M. Martinez-Villacampa, M. Benavides, M. Gomez, A. Massutti, B. Marcuello, E. Constenla, M. Cámara, J.C. Carrato, A. Dueñas, R. Reboredo, M. Navarro, M. Díaz-Rubio, E.